Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11.pdf
PDF 3 MB Posted
- Solicitation number
- 36C24225Q0175
About this file
This is an asbestos survey report (Volume II) for Building 1 at the Syracuse VA Medical Center, conducted in 2011 by Mabbett & Associates and O'Brien & Gere under Contract VA528-P-0738. The survey identified 35 homogeneous areas containing asbestos materials after analyzing 1,142 bulk samples, of which 33 contained asbestos greater than 1%. The building is a twelve-story inpatient/outpatient facility of approximately 950,000 square feet built in 1953.
The survey found asbestos-containing materials including floor tiles, mastics, thermal system insulation, laboratory counter tops, caulk, transite and tar residue. Several areas of significantly damaged or damaged friable asbestos-containing materials were identified requiring immediate abatement or repair, including pipe insulation in multiple locations across different floors and broken transite countertops. The report includes detailed sampling methodology, analytical results, location maps, and quantities of identified materials, though notes some areas were inaccessible including pipe chases, wall interiors, and areas requiring destructive testing.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Specifications Asbsetos Modification CLC 05 08 24.pdf | ||
| 36C24225Q0175_1.docx | DOCX document | |
| Wage Determinations- 2015-4163 rev 26 7-22-24.pdf | ||
| SOW Phase 3 Air Monitoring 8th Floor CLC.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
VOLUME II
ASBESTOS CONTAINING MATERIAL
SURVEY REPORT
BUILDING 1
VISN 2
Syracuse VA Medical Center
800 Irving Avenue Syracuse, NY 13210
Project No. 2010009.002
March 30, 2011
333 West Washington Street Syracuse, NY 13202
Telephone: (315) 956-6800 Facsimile (315) 463-7554 www.obg.com
5 Alfred Circle Bedford, MA 01730-2318
Telephone: (781) 275-6050 Toll Free: (800) 877-6050 Facsimile: (781) 275-5651 info@mabbett.com www.mabbett.com
© 2011, Mabbett & Associates, Inc.
http://www.obg.com/� mailto:info@mabbett.com� http://www.mabbett.com/�
Syracuse VAMC - Building 1 March 2011 ©2011, Mabbett & Associates, Inc. Page i Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
ACKNOWLEDGMENT
This Asbestos Containing Materials (ACM) Building Survey Report was prepared for the Veterans Integrated Network System (VISN 2) in accordance with an established scope of work as defined in Contract Number VA528-P-0738. The information presented herein is based on the facts and information conveyed to or received by O’Brien & Gere (OBG) and/or Mabbett & Associates, Inc. (M&A) during the preparation of this report. If the information provided to OBG and/or M&A that was used in preparing this report is incorrect, incomplete, or subject to change, OBG and M&A would wish to alter their opinion(s) accordingly. In addition, the professional opinions and information contained in this report are based solely on the requirements of the applicable regulations and technical data as known to OBG and M&A as of the date of this report and considered applicable to this report.
This individual building report from Volume II which contains building specific asbestos findings is part of the Comprehensive Veterans Affairs Medical Center (VAMC) Asbestos Survey Report consisting of:
Volume I - General
Chapter 1 - Introduction and Executive Summary with Supporting Documentation Chapter 2 - Summary of ACM Building Results Tables
Volume II – Individual Building Reports
Individual Building Report Chapters including:
• Introduction and Executive Summary
• Building Description Summary
• Asbestos Survey Methodology
• Relevant Asbestos Findings for the Building
(Including Summary Tables and Floor Plans Identifying ACM Locations)
Volume III – Appendices and Supporting Data
Appendix A - Asbestos Laboratory Analysis Reports and Laboratory Certifications Appendix B - Personnel Certifications & Licenses
Volume IV – Asbestos Operations & Maintenance (O&M) Plan
Asbestos Operations & Maintenance (O&M) Plan
©2011, Mabbett & Associates, Inc. Page ii Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
This report was prepared by the following O’Brien & Gere personnel:
James B. Evans Project Associate New York State Asbestos Building Inspector/Management Planner 89-01697
This report has been reviewed and approved by:
O’BRIEN & GERE
John A. Shaheen, P.E.
Managing Engineer New York State Asbestos Building Inspector/Management Planner 89-02931
MABBETT & ASSOCIATES, INC.
Michael F. Delaney Project Manager New York State Asbestos Building Inspector/Management Planner 02-16232
©2011, Mabbett & Associates, Inc. Page iii Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
TABLE OF CONTENTS
Description Page
1.0 INTRODUCTION & EXECUTIVE SUMMARY
2.0 BUILDING DESCRIPTION
3.0 ASBESTOS SURVEY
3.1 Sampling Methodology
3.2 Analytical Methodology
3.3 Summary of Asbestos Containing Material Findings
4.0 LIMITATIONS
5.0 CLOSING REMARKS
Tables Table 1 – Specific Inaccessible Areas Table 2 – Summary of Positive Asbestos Containing Materials Table 3 – Summary of ACM Building Results............................................................ Appendix A
Figures Figure 1 – Asbestos Survey Summary Plan - Building 1, Sub-basement Figure 2 – Asbestos Survey Summary Plan - Building 1, Basement Figure 3 – Asbestos Survey Summary Plan - Building 1, Ground Floor Figure 4 – Asbestos Survey Summary Plan - Building 1, Floor 1 Figure 5 – Asbestos Survey Summary Plan - Building 1, Floor 2 Figure 6 – Asbestos Survey Summary Plan - Building 1, Floor 3 Figure 7 – Asbestos Survey Summary Plan - Building 1, Floor 4 Figure 8 – Asbestos Survey Summary Plan - Building 1, Floor 5 Figure 9 – Asbestos Survey Summary Plan - Building 1, Floor 6 Figure 10 – Asbestos Survey Summary Plan - Building 1, Floor 7 Figure 11 – Asbestos Survey Summary Plan - Building 1, Floor 8 Figure 12 – Asbestos Survey Summary Plan - Building 1, Floor 9 Figure 13 – Asbestos Survey Summary Plan - Building 1, Floors 10 & 11 Figure 14 – Asbestos Survey Summary Plan - Building 1, Exterior Building Plan
Appendices Appendix A – Table 3, Summary of ACM Building Results
©2011, Mabbett & Associates, Inc. Page 1 of 15 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
1.0 INTRODUCTION & EXECUTIVE SUMMARY
Mabbett and Associates, Inc. (M&A), with O’Brien & Gere, Inc. as a sub-contractor performed surveys for suspect asbestos containing building materials (ACM). Surveys were performed of selected buildings at the VAMC located at 800 Irving Avenue in Syracuse, NY, under Contract VA528-P-0738. A complete list of buildings surveyed is in Volume I of this report. Site survey work was performed during July and August 2010, by appropriately credentialed personnel. Bulk samples of suspected ACM were collected and submitted to a certified analytical laboratory for asbestos analysis by polarized light microscopy (PLM) using stop positive methodology and transmission electron microscopy (TEM) as required by New York State Environmental Laboratory Approval Program (ELAP). The survey effort involved the collection of the following samples, resulting in the following conclusions:
• 1,142 bulk samples for suspect ACM were collected and analyzed in this building.
• Based on laboratory analysis 33 of the collected samples contained asbestos greater than 1%. 6 homogenous materials were presumed ACM (PACM) based on the VISN 2 sample protocol.
• 35 homogeneous areas have been identified to be ACM. These areas were presumed, previously identified, and/or have been identified during this survey to be ACM.
• The identified ACMs generally consisted of floor tiles, mastics, thermal system insulation, laboratory counter tops, caulk, transite and miscellaneous tar residue.
A summary including a condition assessment, material description, and quantities can be found in Table 2 and drawings identifying the approximate locations and quantities of the ACM can be found in the Figures portion of this Volume II Report.
• The ACMs have been added to the O&M Plan that can be found as Volume IV of part of the Comprehensive VAMC Asbestos Survey Report. The O&M Plan provides detailed procedures to safely manage the asbestos that will remain in place.
• Based on the findings of this survey, OBG/M&A identified significantly damaged or damaged friable ACMs in this building that are recommended for abatement or immediate repair:
o Pipe fitting insulation and associated debris in DG24, D-wing, ground floor o Pipe fitting insulation above the ceiling of D113, D-wing, first floor o Pipe fitting insulation and associated debris above the ceiling of D313, D-wing third floor o Pipe insulation and debris within a wall chase, C-wing room CL-15, basement floor o Pipe insulation within a wall chase, A-wing room A536, fifth floor o Pipe insulation within a wall chase, A-wing room A745, seventh floor o Broken transite countertops in NL30
©2011, Mabbett & Associates, Inc. Page 2 of 15 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
The purpose of this survey was to identify ACM and evaluate the associated potential risk of identified ACM to staff, patients and visitors. While the information contained in this report may be useful for planning future renovation projects it is not the intent of this survey to identify ACM in inaccessible areas requiring destructive sampling or to be the sole basis for specifications for abatement, renovation, or demolition projects.
This building report consists of a summary of findings, floor plans indicating positive homogeneous areas, and detailed analytical findings for the specific surveyed building materials. Laboratory certificates of analysis for this building report are available in Volume III of the Comprehensive VAMC Asbestos Survey Report.
2.0 BUILDING DESCRIPTION
According to information provided by the VAMC Office of Facilities Management and observations made by the OBG/M&A team at the time of the survey, Building 1 was a twelve-story Inpatient and Outpatient Care Building with a basement and sub-basement, built in 1953 and occupied approximately 950,000 square feet.
3.0 ASBESTOS SURVEY
3.1 Sampling Methodology
A visual screening inspection was conducted by state licensed asbestos inspectors throughout the building to identify locations of suspect ACM. Only areas that were accessible during the field work phase were inspected. Every effort was made during the initial field survey work to access areas as necessary to complete the survey. However, if any areas remained inaccessible to the survey team, they are indicated in Table 1 below:
Table 1 – Specific Inaccessible Areas Syracuse VA Medical Center, Building 1
Building Floor Room No. Reason Area Was Inaccessible and Survey Impacts, If Applicable
Multiple pipe chases; lack of access and space.
The majority of fourth floor spaces were inspected during another project by O’Brien & Gere in 2009; accordingly, data from the previous survey were utilized in this report and a re-survey was not performed. Asbestos-containing materials identified in the 2009 report are included in Tables 2 and 3 and indicated on the report figures unless the 2010 survey found that the materials were no longer present. If the 2010 survey found that previously-identified ACM was no longer present, materials were not included in Tables or figures and samples of these materials, though included on figures, were listed with a note that the material was no longer present.
Other general areas that were inaccessible or where destructive sampling would be required and were therefore not inspected/sampled are identified below:
• Within walls • Within fire doors
• Enclosed pipe/duct chases • Inside mechanical equipment/ductwork
• Above fixed drywall or plaster ceilings • Intact ceramic tile, grout, and mastic
• Intact Terrazzo floor tile and mastic • Intact laboratory bench tops
©2011, Mabbett & Associates, Inc. Page 3 of 15 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
• Roofs, associated materials, and • Elevator brakes and clutches equipment that may void roof warranties
ACM surveys should be performed prior to any proposed renovations or maintenance of areas and materials identified above and the areas and suspect materials should be presumed ACM unless proven otherwise.
Bulk samples were collected of suspect ACM in accordance with US Environmental Protection Agency (EPA) Asbestos Hazard and Emergency Response Act (AHERA) and the M&A Team Program Standard Operating Procedure (SOP), dated June 2, 2010. Bulk suspect ACM sampling was generally conducted according to the following sampling plan:
(a) Friable surfacing material:
(1) At least three bulk samples shall be collected from each homogeneous area that is 1,000 ft2 or less.
(2) At least five bulk samples shall be collected from each homogeneous area that is greater than 1,000 ft2 but less than or equal to 5,000 ft2.
(3) At least seven bulk samples shall be collected from each homogeneous area that is greater than 5,000 ft2.
(b) Thermal system insulation:
(1) At least three bulk samples shall be collected from each homogeneous area of thermal system insulation.
(2) At least one bulk sample shall be collected from each homogeneous area of patched area of thermal system insulation.
(3) Sufficient samples shall be collected from elbows and fittings to determine if it contains ACM.
(4) Bulk samples shall not be collected from any homogeneous area where the state licensed asbestos inspector determined that the thermal system insulation is fiberglass, foam glass, rubber, or other non suspect material.
(c) Miscellaneous material:
(1) At least two bulk samples shall be collected from each homogeneous area that is less than 100 ft2.
(2) Sufficient samples shall be collected from each homogeneous area that is greater than 100 ft2.
To limit the risk of exposure to ACM and to control costs, where previous surveys, labeling, and/or associated analytical reports indicated a material had been previously determined to be ACM, with a reasonable degree of accuracy and confidence by the inspector the material was generally NOT re-sampled. These materials are included in Table 2 and on the CADD plans of this building report. Associated previous laboratory results and/or supporting documentation are available in Attachment A of the Volume I portion of the comprehensive report. In particular, sampling performed by O’Brien & Gere included in a report dated March 30, 2009 was relied on for this report. Sample locations and ACM locations identified in the 2009 report are indicated on figures in this document.
©2011, Mabbett & Associates, Inc. Page 4 of 15 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
3.2 Analytical Methodology
The bulk samples collected were submitted under chain of custody procedures to America Science Team New York, Inc. (AmeriSci New York) for polarized light microscopy (PLM) and transmission electron microscopy (TEM) analysis as required by the New York State Environmental Laboratory Approval Program (ELAP). PLM analysis of friable materials was performed using NYS ELAP Method 198.1. Samples of Non-friable Organically Bound (NOB) materials were analyzed by PLM (NYS ELAP Method 198.6) subsequent to matrix reduction.
NOB samples that were identified as non-ACM by PLM methods were re-analyzed by TEM (NYS ELAP Method 198.4) for confirmation purposes. AmeriSci New York is accredited by the American Industrial Hygiene Association (AIHA) and participates in the National Voluntary Laboratory Accreditation Program (NVLAP Lab Code 200546-0). Copies of the laboratory accreditations are included in Volume III of the Comprehensive VAMC Asbestos Survey Report.
Bulk sample results including positive and negative results are summarized in Table 3 – Summary of ACM Building Results. The EPA and Part 56 of Title 12 of the Official Compilation of Codes, Rules and Regulations of the State of New York (12 NYCRR Part 56) defines any material that contains greater than one percent (>1%) asbestos as being an ACM. As such, the analytical laboratory identified bulk samples as positive for asbestos that met the regulatory criteria of greater than one percent (>1%) asbestos.
3.3 Summary of Asbestos Containing Material Findings
3.3.1 Data Tables and Laboratory Results
Collected bulk samples confirmed by the analytical laboratory to contain >1% asbestos and previously identified ACM are listed in Table 2 - Summary of Positive Asbestos Containing Materials. An analytical laboratory summary for each of the collected bulk samples is listed in Table 3 - Summary of ACM Building Results. Volume III of the Comprehensive VAMC Asbestos Survey Report includes copies of the laboratory certificates of analysis.
©2011, Mabbett & Associates, Inc. Page 5 of 15 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 2 - Summary of Positive Asbestos Containing Material Representative Sample Locations
Percent and Type of Asbestos Sample
No.
Sample Location (Bldg # - Floor -
Room #)
Associated
ACM
Location(s) Description of
Material
PLM TEM
Estimated Total
Quantity Condition
VISN 2
Risk
Hazard Category
1-4*
Basement and Sub-Basement, A, B and C Wings
B8A 1-
Basement-
CL21
B8B 1-
Basement
-CL21
B8C 1-
Basement
-CL21
B8D 1-
Basement
-AL18B
CL21,
Corr 10, AL18B, NL35, B310, B343, B345, C305, C317, C319
12” Floor Tile-Beige with Brown & White Flecks
PLM
TEM
Chrysotile 12.7%
NA/PS
850 SF Good 4
B17A 1-
Basement
-CL15
B17B 1-
Basement
-CL15
CL15 (within wall chase)
Premolded Plaster (Mag) Pipe Insulation & Associated Debris
Chrysotile 3.8% Amosite 15.4%
NA/PS
30 LF
Minor Damage (Pipe), Significant Damage (Debris)
B39A 1-Sub- Basement
B39B 1-Sub- Basement
B39C 1-Sub- Basement
B39D
1-Sub- Basement
Boiler Room
Sub- Basement, Sub- Basement
Boiler Room
Tar on Cork Pipe Insulation
Chrysotile <1%
Chrysotile 1.5% 490 LF Minor
Damage 3
Ground (G) through Eleventh Floors, A, B and C Wings
5A 1-10-NE
Door
5B 1-10-SE
Door
10th Floor Door Frame Caulk
Chrysotile 5.8%
42 LF Good 4
14A 1-G-CG43
14B 1-G-CG43
CG43
Tan Mastic Under Linoleum-Red/Cream Fleck
Chrysotile 1.4%
1800 SF Good 4
15A 1-G-CG43
15B 1-G-CG43
15C 1-G-CG43
CG43 Black Mastic Behind Wall Panel
Chrysotile 3.3%
990 SF Good 4
19A 1-G-CG37 CG37, CG39 Black Mastic under Carpet
Chrysotile 3.2%
230 SF Good 4
20A 1-9-A903
20B 1-9-A903 20C 1-9-A903
A103, A903 Residual Black Mastic
- Floor
Chrysotile 4.5%
250 SF Good 4
©2011, Mabbett & Associates, Inc. Page 6 of 15 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 2 - Summary of Positive Asbestos Containing Material Representative Sample Locations Syracuse VA Medical Center, Building 1
Percent and Type of Asbestos Sample
No.
Sample Location (Bldg # - Floor -
Room #)
Associated
ACM
Location(s) Description of
Material
PLM TEM
Estimated Total
Quantity Condition
VISN 2
Risk
Hazard Category
1-4* 42A 1-9-A922B
42B 1-9-A922B
42C 1-7-A745- Inside Wall
A536, A745, A922B
Millboard Pipe Insulation
Chrysotile 4.8%
12 LF
Good (A745
1 LF Minor Damage)
©2011, Mabbett & Associates, Inc. Page 7 of 15 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 2 - Summary of Positive Asbestos Containing Material Representative Sample Locations Syracuse VA Medical Center, Building 1
Percent and Type of Asbestos Sample
No.
Sample Location (Bldg # - Floor -
Room #)
Associated
ACM
Location(s) Description of
Material
PLM TEM
Estimated Total
Quantity Condition
VISN 2
Risk
Hazard Category
1-4*
7A 1-9-A918A AL08, AL10,
AL17, AL18A,
AG13, AG13A,
BG05, BG11,
BG11A, CG02,
CG09, CG19,
CG19A,
CG19C, CG20,
CG33, CG35,
CG38A, DG14,
DG22A, NG45,
NG47, B102,
B106, B111, D113A, Closet at 1S6, C220, C222, Corr 230A, Corr 235, C261, C261A, C263, C265, C267, C269, C271, C273, Corr 235A, D204, D222, D222A, D223, B301, A313, A318, A318A, A323, A323A, A330, A337, A340, Corr
310, Corr 310A, C307, C380, A509, A510, Corr 510, A506, A520, A524, A528, A529, A530, A531, A538, A539, A540, A541, A542, A544, A545, A546, A547, A548, A549, A550, C500, A608, A610, A611, A613, A615, A615A, A618, A624, A628, A629, A630, A631, A636, A643, A644, A645, A646, B606, B612, B618, B624, B628, B628A, B633, B635, B635A, B636, B637, Brown Mastic Under 12” Floor Tile - Cream with Grey Fleck
Chrysotile 1.9% (Sample 47F)
31,400 SF Good 4
©2011, Mabbett & Associates, Inc. Page 8 of 15 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 2 - Summary of Positive Asbestos Containing Material Representative Sample Locations Syracuse VA Medical Center, Building 1
Percent and Type of Asbestos Sample
No.
Sample Location (Bldg # - Floor -
Room #)
Associated
ACM
Location(s) Description of
Material
PLM TEM
Estimated Total
Quantity Condition
VISN 2
Risk
Hazard Category
1-4*
47A (cont) 1-9-A918A
B640, B641, B642, B643, B644, B645, B646, B647, C610, C613, C614, C615, C628, C634, C636, C637, C638, C639, A706, A706A, A706B, A748, B705, B706, B721, B721A, B721B, B723, B724, B725, B746, B747, B748, Corr 725, A807, A809, A806A, A811, A814, A815, A818, A820, A821, A836, A838, A839, A840, A841, A842, A843, A844, Corr
815, (B)801, B806, B804, B807, B809, B820, B823, C802, C806, C808, C808A, C809, C810, C811, C812, C814, C816, C816A, C818, C820, C821, C821A, C822, C823, C823A, C825, C825A, C827, C832, C836, C837, A911, A911A, A911B, A915, A915A, A915B, A916, A918A, C900, C901, C902, C916, 9S3
Brown Mastic Under 12” Floor Tile - Cream with Grey Fleck
(Sample 47F)
31,400 SF Good 4
©2011, Mabbett & Associates, Inc. Page 9 of 15 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 2 - Summary of Positive Asbestos Containing Material Representative Sample Locations Syracuse VA Medical Center, Building 1
Percent and Type of Asbestos Sample
No.
Sample Location (Bldg # - Floor -
Room #)
Associated
ACM
Location(s) Description of
Material
PLM TEM
Estimated Total
Quantity Condition
VISN 2
Risk
Hazard Category
1-4*
47B 1-9-9S3- 9th Floor
47C 1-8-B823
47D 1-7-B705
47E 1-5-A510
47F 1-2-C222
47G 1-2-Corr
76A 1-8-B804
76B 1-8-B804
76C 1-3-A337
B205, B209, B211, B213, B214, B215, B217, B219, B221, B226, B230, B232, B237, B238, B239, B240, B241, B242, B243, B244, B245, B246, B247, B248, B249, A337, C318, C321, C323, C344, C348, C361, C362, C362A, C367, C367A, C369, C371, C381, B804, D113A
Black Mastic Under 12” Floor Tile - Cream with Tan Fleck
Chrysotile 3.4%
NA/PS
4,150 SF Good 4
83A 1-8-B823B
83B 1-8-B823B B823B
Miscellaneous Roofing Tar on Brick
Wall
Chrysotile 5.6%
NA/PS
30 SF Good 4
84A 1-7-A709
84B 1-7-A709
84C 1-7-A713
A709, A713, A715
12” Floor Tile - Green with White Fleck
Chrysotile 2.4%
NA/PS
320 SF Good 4
85A 1-7-A709 A709, A713, A715
Black Mastic Under 12” Floor Tile - Green with White Fleck
Chrysotile 2.3%
NA/PS
320 SF Good 4
86A 1-7-A741
86B 1-7-A741
CG25A,
A741, A744, A746
12” Floor Tile - Tan with White Streaks
Chrysotile 2.1%
400 SF Good 4
©2011, Mabbett & Associates, Inc. Page 10 of 15 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 2 - Summary of Positive Asbestos Containing Material Representative Sample Locations Syracuse VA Medical Center, Building 1
Percent and Type of Asbestos Sample
No.
Sample Location (Bldg # - Floor -
Room #)
Associated
ACM
Location(s) Description of
Material
PLM TEM
Estimated Total
Quantity Condition
VISN 2
Risk
Hazard
106A
1-6-A609
106B
1-6-A609
106C
1-6-C635
106D
1-6-C635
106E 1-6-C635
AG20, AG23,
AG24, AG25,
A309, A536, A609, CORR 610,
C633, C635, A703, A708, A712, A716, A720, A742, A736, A738, A738A, A742, Corr 703, Corr 720, 12” Floor Tile -Light Grey with White Fleck
Chrysotile 2.0%
NA/PS
1,290 SF Good 4
107A 1-6-A609
107B 1-6-A609
107C 1-6-C635
107D 1-6-C635
107E 1-5-A545
AG20, AG23,
AG24, AG25,
A309, A536, A609, Corr 610, C633, C635, A703, A708, A712, A716, A742, A736, A738, A738A, Corr 703, Corr 720
Black Mastic Under 12” Floor Tile - Light
Grey with White Fleck
NA/PS
1,290 SF Good 4
110A 1-6-C644
110B 1-6-C644
C644, C645, C646, C647, C648, C649, C650, C651, C652, C653, C654, C655
12” Floor Tile - Light Olive with Tan Stripes and associated mastic
Chrysotile 2.2%
NA/PS
1,100 SF Good 4
116A 1-4-C402
116B 1-4-C402 C400, C402, C404 Old gray floor tile under carpet
Chrysotile 2.9%
NA/PS
150 SF Good 4
122A 1-3-Corr.
@ C343
122B 1-3-Corr.
@ C343
Corr 340, B503
12” Floor Tile - Dark Grey with White
Streaks
Chrysotile 4.5%
NA/PS
375 SF Good 4
123A 1-3-
Corridor @ C343
Corr 340, B503
Black Mastic Under 12” Floor Tile - Dark
Grey with White
Chrysotile 2.3%
NA/PS
375 SF Good 4
129A 1-2-C216
129B 1-2-C215 C215, C216
Mastic Under Floor Leveler (Beneath
Linoleum)
Chrysotile 3.3%
NA/PS
450 SF Good 4
138A 1-3-Corr.
@ A337
138B 1-3-341
Corr at A337, A339, A341, B304
Leveling Compound & Black Mastic
Residue Beneath Carpet
Chrysotile 3.5%
NA/PS
300 SF Good 4
170A 1-1-B130
170B 1-1-B130
170C 1-1-B130
NL30, B130,
C380 (sink) Transite Countertop
Chrysotile 22.2%
NA/PS
1,975 SF
Good
Damaged
NL30
120 sf
NL30
©2011, Mabbett & Associates, Inc. Page 11 of 15 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 2 - Summary of Positive Asbestos Containing Material Representative Sample Locations Syracuse VA Medical Center, Building 1
Percent and Type of Asbestos Sample
No.
Sample Location (Bldg # - Floor -
Room #)
Associated
ACM
Location(s) Description of
Material
PLM TEM
Estimated Total
Quantity Condition
VISN 2
Risk
Hazard Category
1-4*
177 PACM
C219, C221, C272, A303, C343, Corr 350, C360, A503, A627, A721, Corr
800, Corr 810, Corr 830, Corr 840, A913, Corr 910, Corr 900/935
9” Floor Tile – various colors – and associated tile mastic
PACM
PACM
3,600 SF Good 4
178 PACM B266, B265B,
B265C
Metal Wall Panels with Presumed ACM Filler Within
PACM
300 SF Good 4
Listed in
Report
Fourth Floor 12” Floor Tiles – various colors
PACM
6,200 SF Good 4
Listed in
Report
C527 Door Frame Caulk
PACM
17 LF Good 4
Listed in
Report
Fourth Floor Mudded (Plaster) Pipe Fitting Insulation
PACM
106 EA Good 3
182 PACM
Throughout Building – Refer to Figures
Pipe and Pipe Fitting Insulation within chases
84 Chases Good 3
Ground (G) through
Fourth Floors D-Wing Only
D10A 1-G-DG24
D10B 1-G-DG24
D10C 1-G-DG24
D10D 1-1-D113 D10E 1-1-D113 D10F 1-1-D113
D10G 1-1-Corr.
D10H 1-2-D217
D10I 1-3-Corr.
D10J 1-3-D304
D10K 1-3-D304
DG24, DG02,
D101, D113, D117 Corr 145, D223, D217, D205, D304, D311, D313, D314, Corr 345
Mudded (Plaster)
Pipe Fitting Insulation
Chrysotile 40%
208 EA
Good
Damaged (in DG24)
(in DG24)
D13A 1-G-DG22
D13B 1-G-DG22
D13C 1-3-D304
D13D 1-3-D304
D13E 1-3-D311
D13F 1-3-D311
DG22, B119,
C240B, D304, D311, D407, Sink Anti-Corrosive Coating-Black
Chrysotile 6.5%
48 SF Good 4
©2011, Mabbett & Associates, Inc. Page 12 of 15 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 2 - Summary of Positive Asbestos Containing Material Representative Sample Locations Syracuse VA Medical Center, Building 1
Percent and Type of Asbestos Sample
No.
Sample Location (Bldg # - Floor -
Room #)
Associated
ACM
Location(s) Description of
Material
PLM TEM
Estimated Total
Quantity Condition
VISN 2
Risk
Hazard
D25A
1-4-D409
D25B 1-4-D409
D409, D412, CL49, AL13,
CORR120,
CORR120A
12” Floor Tile-Tan with Brown & White
Chrysotile 3.2%
1,200 SF Good 4
D32A
1-4-D407
D32B 1-4-D407
D407, B128, B129, B130, B130A, B139- 150, M304
12” Floor Tile-Tan with Dark Beige
Chrysotile 3.4%
1,375 SF Good 4
D33A 1-4-D407
D33B 1-4-D407
D407, B139- 150, B128, B129, B130, B130A, M304
Black Mastic Under 12” Floor Tile-Tan with Dark Beige
Chrysotile 2.5%
NA/PS
1,375 SF Good 4
D37A 1-4-D415
D113, D213, D213B, D213C, D217, D215, D205, D304, D311, D313 D314, D405, D407, D415
Fume Hood/Incubator Lining
Chrysotile 23.5%
NA/PS
815 SF Good 4
D58A 1-3-Corr.
D58B 1-3-Corr.
CORR 345 Freezer Caulk- Off White
Chrysotile 1.7%
NA/PS
40 LF Good 4
170 PACM
DG18, D113,
D117, D205, D205A, D209, D213, D213C, D215 D215A, D217 D326, D326A, D326B, D407, D405
Transite Countertop
PACM
1,700 SF Good 4
177 PACM
Throughout
D-wing (Refer to drawings)
9” Floor Tile – various colors – and associated tile mastic
PACM
5,200 SF Good 4
182 PACM D416 Pipe Insulation
2 LF Good 3
Exterior (EX)
EX3A 1-EX-
North
EX3B 1-EX-
North
Exterior Old White Residual
Window Frame Caulking
Chrysotile 7.9%
NA/PS
14,000 LF Good 4
EX5A 1-EX-
North
EX5B 1-EX-
North
EX5C 1-EX-
North
Exterior Tan & Grey Louver Frame Caulk
Chrysotile 3.1%
390 LF Good 4
©2011, Mabbett & Associates, Inc. Page 13 of 15 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 2 - Summary of Positive Asbestos Containing Material Representative Sample Locations Syracuse VA Medical Center, Building 1
Percent and Type of Asbestos Sample
No.
Sample Location (Bldg # - Floor -
Room #)
Associated
ACM
Location(s) Description of
Material
PLM TEM
Estimated Total
Quantity Condition
VISN 2
Risk
Hazard Category
1-4*
EX12A 1-EX-East
EX12B 1-EX-East Exterior Transite Fascia
Chrysotile 17.4%
NA/PS
180 SF Good 4
Footnotes:
SF – Square Feet LF – Linear Feet EA – Each CF – Cubic Feet
NAD – No Asbestos Detected N/A – Not Applicable NA – Not Analyzed NA/PS – Not Analyzed, Positive Stop PACM – Presumed Asbestos-Containing Material
* The VISN 2 Risk Hazard Assessment Scale 1 – 4 is a relative indicator of the risk and need for response/abatement. The rating assigned by an Asbestos Management Planner, takes into account: condition, friable vs. non-friable, accessibility, occupancy (e.g. continuous, intermittent or occasional and patients/staff/visitors), potential for air erosion, potential for vibration damage, potential for disturbance / damage (e.g. exposed and in an accessible location), and potential for water damage. The following is a list of the VISN 2 Risk Hazard Assessment Scale:
Category 1: represents significantly damaged friable ACM in locations with moderate to high occupancy by staff and/or patients. A significantly damaged condition is a condition with damage greater than or equal to 10% of the total surface area or 25% localized damage. Category 1 ACM should be abated or repaired as soon as possible to minimize any potential hazards posed by the asbestos.
Category 2: represents significantly damaged and damaged friable ACM in locations not frequently occupied. Category 2 ACM should be abated or repaired as soon as possible to minimize any potential hazards posed by the asbestos.
Category 3: represents ACM in at least good condition (friable or non-friable ACM that could become friable). A good condition is a condition with damage less than or equal to 1% of its total area. Category 3 should be visually surveyed semi-annually as part of the routine O&M Plan and should be considered for abatement or corrective action if conditions deteriorate or circumstances allow.
Category 4: represents non-friable ACM in good or excellent condition but should be regularly inspected as part of the O&M Plan.
3.3.2 CADD Drawings
The location of each bulk sample and its associated sample ID are shown on the CADD drawings in the Figures Section of this report. Each positive ACM sample location is colored red and marked with an asterisk (*). Samples presumed to be ACM based on positive stop analysis are colored red and marked with a double asterisk (**). Areas containing ACM have been indicated with hatching to identify the locations of the identified ACM. Previously
©2011, Mabbett & Associates, Inc. Page 14 of 15 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11 identified ACM not sampled during this survey are also included on the drawings. In particular, samples and ACM locations included in the March 30, 2009 report have been included in this report, including in Tables 2 and 3 and on figures. Locations of samples from the 2009 report are generalized, as they were reported by space number but precise sample locations within the space were not recorded.
ACM abatement or newly identified ACM should be annotated on the CADD drawings by the VAMC going forward.
4.0 LIMITATIONS
This inspection report is the result of a diligent search of the building for ACM. Only accessible areas were included in this survey. However comprehensive this inspection appears, it does not claim to have identified all of the ACM that could be present in the facility. OBG/M&A’s survey was performed with limitations inherent to visual non-destructive inspections.
OBG/M&A has conducted this assessment with reasonable care and has performed this project within generally accepted industry standards. There can be no assurances, and OBG/M&A make no assurances, that the information, research, and technology used to prepare this report may not change in the future, thus affecting the results provided. The report is designed to aid the building owner, architect, construction manager, general contractors, and potential asbestos abatement contractors in locating ACM. Under no circumstances is the report to be utilized as a bidding document or as a project specification document since it does not have all the components required to serve as an Asbestos Project Design document or an Abatement Work Plan. Prior to renovation, the collection of additional samples may be required of inaccessible areas such as wall cavities, pipe chases, etc.
5.0 CLOSING REMARKS
Prior to initiating plans for maintenance, renovation or demolition activities, the VAMC should review the asbestos survey results to identify if any of these materials will be disturbed by proposed work activities.
The purpose of the ACM survey was to identify ACM in the building within the limitations of the survey for worker and patient protection purposes. In regards to asbestos, any suspect material encountered or expected to be encountered during renovation/demolition that is not identified in this report as being non-ACM should be assumed to be ACM unless sample results prove otherwise. Suspect ACM that may be present within the walls, above inaccessible hard ceilings, or in other inaccessible locations, that were not inspected should be assumed to contain asbestos if discovered during any renovation process until verified otherwise.
If ACM must be disturbed, the ACM must be removed by a licensed asbestos abatement contractor and be performed in accordance with the applicable regulations. If proposed work activities will not disturb ACM, continuous monitoring of ACM should be conducted throughout work activities to ensure the ACM remains in an intact condition. Additionally, prior to commencing work activities, contractors involved with the work activities should be made aware of the location of ACM, within the building in which they will be working. Additional information regarding asbestos management and the Operations & Maintenance (O&M) Plan
©2011, Mabbett & Associates, Inc. Page 15 of 15 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11 is outlined in the VAMC campus wide Asbestos O&M Plan available in Volume IV of the Comprehensive VAMC Asbestos Survey Report.
Figures on e-qu ar te r i nc h on e fo ot on e-ei gh th in ch o ne fo ot
Revisions Date th re e-ei gh th in ch o ne fo ot on e-ha lf in ch o ne fo ot
0n e an d on e-ha lf in ch es o ne fo ot on e in ch o ne fo ot th re e-qu ar te rs in ch o ne fo ot th re e in ch es o ne fo ot
PROJ. NO.
DATE
CHECKED DRAWNBuilding Number
Location
Project TilteDrawing Title
Floor
Dwg. OF qu ar te r i nc h on e fo ot on e-ei gh th in ch o ne fo ot
Revisions Date th re e-ei gh th in ch o ne fo ot on e-ha lf in ch o ne fo ot
0n e an d on e-ha lf in ch es o ne fo ot on e in ch o ne fo ot th re e-qu ar te rs in ch o ne fo ot th re e in ch es o ne fo ot
PROJ. NO.
DATE
CHECKED DRAWNBuilding Number
Location
Project TilteDrawing Title qu ar te r i nc h on e fo ot on e-ei gh th in ch o ne fo ot
Revisions Date th re e-ei gh th in ch o ne fo ot on e-ha lf in ch o ne fo ot
0n e an d on e-ha lf in ch es o ne fo ot on e in ch o ne fo ot th re e-qu ar te rs in ch o ne fo ot th re e in ch es o ne fo ot
PROJ. NO.
DATE
CHECKED DRAWNBuilding Number
Location
Project TilteDrawing Title qu ar te r i nc h on e fo ot on e-ei gh th in ch o ne fo ot
Revisions Date th re e-ei gh th in ch o ne fo ot on e-ha lf in ch o ne fo ot
0n e an d on e-ha lf in ch es o ne fo ot on e in ch o ne fo ot th re e-qu ar te rs in ch o ne fo ot th re e in ch es o ne fo ot
PROJ. NO.
DATE
CHECKED DRAWNBuilding Number
Location
Project TilteDrawing Title qu ar te r i nc h on e fo ot on e-ei gh th in ch o ne fo ot
Revisions Date th re e-ei gh th in ch o ne fo ot on e-ha lf in ch o ne fo ot
0n e an d on e-ha lf in ch es o ne fo ot on e in ch o ne fo ot th re e-qu ar te rs in ch o ne fo ot th re e in ch es o ne fo ot
PROJ. NO.
DATE
CHECKED DRAWNBuilding Number
Location
Project TilteDrawing Title qu ar te r i nc h on e fo ot on e-ei gh th in ch o ne fo ot
Revisions Date th re e-ei gh th in ch o ne fo ot on e-ha lf in ch o ne fo ot
0n e an d on e-ha lf in ch es o ne fo ot on e in ch o ne fo ot th re e-qu ar te rs in ch o ne fo ot th re e in ch es o ne fo ot
PROJ. NO.
DATE
CHECKED DRAWNBuilding Number
Location
Project TilteDrawing Title qu ar te r i nc h on e fo ot on e-ei gh th in ch o ne fo ot
Revisions Date th re e-ei gh th in ch o ne fo ot on e-ha lf in ch o ne fo ot
0n e an d on e-ha lf in ch es o ne fo ot on e in ch o ne fo ot th re e-qu ar te rs in ch o ne fo ot th re e in ch es o ne fo ot
PROJ. NO.
DATE
CHECKED DRAWNBuilding Number
Location
Project TilteDrawing Title qu ar te r i nc h on e fo ot on e-ei gh th in ch o ne fo ot
Revisions Date th re e-ei gh th in ch o ne fo ot on e-ha lf in ch o ne fo ot
0n e an d on e-ha lf in ch es o ne fo ot on e in ch o ne fo ot th re e-qu ar te rs in ch o ne fo ot th re e in ch es o ne fo ot
PROJ. NO.
DATE
CHECKED DRAWNBuilding Number
Location
Project TilteDrawing Title qu ar te r i nc h on e fo ot on e-ei gh th in ch o ne fo ot
Revisions Date th re e-ei gh th in ch o ne fo ot on e-ha lf in ch o ne fo ot
0n e an d on e-ha lf in ch es o ne fo ot on e in ch o ne fo ot th re e-qu ar te rs in ch o ne fo ot th re e in ch es o ne fo ot
PROJ. NO.
DATE
CHECKED DRAWNBuilding Number
Location
Project TilteDrawing Title qu ar te r i nc h on e fo ot on e-ei gh th in ch o ne fo ot
Revisions Date th re e-ei gh th in ch o ne fo ot on e-ha lf in ch o ne fo ot
0n e an d on e-ha lf in ch es o ne fo ot on e in ch o ne fo ot th re e-qu ar te rs in ch o ne fo ot th re e in ch es o ne fo ot
PROJ. NO.
DATE
CHECKED DRAWNBuilding Number
Location
Project TilteDrawing Title qu ar te r i nc h on e fo ot on e-ei gh th in ch o ne fo ot
Revisions Date th re e-ei gh th in ch o ne fo ot on e-ha lf in ch o ne fo ot
0n e an d on e-ha lf in ch es o ne fo ot on e in ch o ne fo ot th re e-qu ar te rs in ch o ne fo ot th re e in ch es o ne fo ot
PROJ. NO.
DATE
CHECKED DRAWNBuilding Number
Location
Project TitleDrawing Title qu ar te r i nc h on e fo ot on e-ei gh th in ch o ne fo ot
Revisions Date th re e-ei gh th in ch o ne fo ot on e-ha lf in ch o ne fo ot
0n e an d on e-ha lf in ch es o ne fo ot on e in ch o ne fo ot th re e-qu ar te rs in ch o ne fo ot th re e in ch es o ne fo ot
PROJ. NO.
DATE
CHECKED DRAWNBuilding Number
Location
Project TilteDrawing Title qu ar te r i nc h on e fo ot on e-ei gh th in ch o ne fo ot
Revisions Date th re e-ei gh th in ch o ne fo ot on e-ha lf in ch o ne fo ot
0n e an d on e-ha lf in ch es o ne fo ot on e in ch o ne fo ot th re e-qu ar te rs in ch o ne fo ot th re e in ch es o ne fo ot
PROJ. NO.
DATE
CHECKED DRAWNBuilding Number
Location
Project TilteDrawing Title qu ar te r i nc h on e fo ot on e-ei gh th in ch o ne fo ot
Revisions Date th re e-ei gh th in ch o ne fo ot on e-ha lf in ch o ne fo ot
0n e an d on e-ha lf in ch es o ne fo ot on e in ch o ne fo ot th re e-qu ar te rs in ch o ne fo ot th re e in ch es o ne fo ot
PROJ. NO.
DATE
CHECKED DRAWNBuilding Number
Location
Project TilteDrawing Title
Appendix A
Table 3 Summary of ACM Building Results
Syracuse VAMC - Building 1 Appendix A – Table 3 – March 2011 ©2011, Mabbett & Associates, Inc. Page 1 of 56 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 3 - Summary of ACM Building Results
Percent and Type of
Asbestos Sample Number
Sample Location (Building, Floor, Location)
Description of Material PLM TEM
Estimated Quantity Units Condition
VISN 2 Risk Hazard
Category 1-4*
BASEMENT (B) AND SUB-BASEMENT SAMPLES
B1A 1-B-CL49 Drywall-Wall NAD NA - - - - - - - -
B1B 1-B-CL19 Drywall-Wall NAD NA - - - - - - - -
B1C 1-B-BL05 Drywall-Wall NAD NA - - - - - - - -
B1D 1-B-Corridor @ Stairwell 4 Drywall-Wall NAD NA - - - - - - - -
B2A 1-B-CL49 Seam Tape-Wall NAD NA - - - - - - - -
B2B 1-B-CL19 Seam Tape-Wall NAD NA - - - - - - - -
B2C 1-B-BL05 Seam Tape-Wall NAD NA - - - - - - - -
B2D 1-B-Corridor @ Stairwell 4 Seam Tape-Wall NAD NA - - - - - - - -
B2E 1-B-CL02A-Shaft 5 Seam Tape-Wall NAD NA - - - - - - - -
B3A 1-B-CL49 Joint Compound- Wall NAD NA - - - - - - - -
B3B 1-B-CL19 Joint Compound- Wall NAD NA - - - - - - - -
B3C 1-B-BL05 Joint Compound- Wall NAD NA - - - - - - - -
B3D 1-B-Corridor @ Stairwell 4
Joint Compound- Wall NAD NA - - - - - - - -
B3E 1-B-CL02A-Shaft
Joint Compound- Wall NAD NA - - - - - - - -
B4A 1-B-CL20 Skim Coat-Wall NAD NA - - - - - - - -
B4B 1-B-AL09 Skim Coat-Wall NAD NA - - - - - - - -
B4C 1-B-CM01 Skim Coat-Wall NAD NA - - - - - - - -
B4D 1-B-CM01 Skim Coat-Wall NA NA - - - - - - - -
B4E 1-B-Stairwell LS8 Skim Coat-Wall NAD NA - - - - - - - -
B4F 1-B-Stairwell 4-
South West Corner
Skim Coat-Wall NAD NA - - - - - - - -
B5A 1-B-CL20 Base Coat-Wall NAD NA - - - - - - - -
B5B 1-B-AL09 Base Coat-Wall NAD NA - - - - - - - -
B5C 1-B-CM01 Base Coat-Wall NAD NA - - - - - - - -
B5D 1-B-CM01 Base Coat-Wall NA NA - - - - - - - -
B5E 1-B-Stairwell LS8 Base Coat-Wall NAD NA - - - - - - - -
©2011, Mabbett & Associates, Inc. Page 2 of 56 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 3 - Summary of ACM Building Results Syracuse VA Medical Center, Building 1
Percent and Type of Asbestos Sample
Number
Sample Location (Building, Floor, Location)
Description of Material PLM TEM
Estimated Quantity Units Condition
VISN 2 Risk Hazard
Category 1-4*
B5F 1-B-Stairwell 4-
South West Corner
Base Coat-Wall NAD NA - - - - - - - -
B6A 1-B-CL23A
2’x4’Ceiling Tile- Tegular/Split with
Pin Dots
NAD NA - - - - - - - -
B6B 1-B-CL23A
2’x4’Ceiling Tile- Tegular/Split with
Pin Dots
NAD NA - - - - - - - -
B6C 1-B-CL23A
2’x4’Ceiling Tile- Tegular/Split with
Pin Dots
NAD NA - - - - - - - -
B7A 1-B-CL23A
Black Tar on
Concrete Wall (Type 1)
NAD NAD - - - - - - - -
B7B 1-B-CL23A
Black Tar on
Concrete Wall (Type 1)
NAD Chrysotile <1% - - - - - - - -
B7C 1-B-CL23A
Black Tar on
Concrete Wall (Type 1)
NA NA - - - - - - - -
B7D 1-B-AL16
Black Tar on
Concrete Wall (Type 1)
NAD Chrysotile <1% - - - - - - - -
B8A 1-B-CL21
12” Floor Tile-
Beige with Brown & White Flecks
Chrysotile 12.7% NA/PS 850 SF Good 4
B8B 1-B-CL21
12” Floor Tile-
Beige with Brown & White Flecks
NA/PS NA/PS Above Above Good 4
B8C 1-B-CL21
12” Floor Tile-
Beige with Brown & White Flecks
NA/PS NA/PS Above Above Good 4
B8D 1-B-AL18B
12” Floor Tile-
Beige with Brown & White Flecks
NA/PS NA/PS Above Above Good 4
B9A 1-B-CL21 Black Mastic Under 8A NAD NAD - - - - - - - -
B9B 1-B-CL21 Black Mastic Under 8B NAD NAD - - - - - - - -
B9C 1-B-CL21 Black Mastic Under 8C NA NA - - - - - - - -
B9D 1-B-AL18B Black Mastic Under 8D
Chrysotile <1%
Chrysotile <1% - - - - - - - -
B10A 1-B-CL29
2’x4’ Ceiling Tile- Large Fissures &
Pin Dots
NAD NA - - - - - - - -
B11A 1-B-CL27 Dark Grey Wall Penetration Mortar NAD NA - - - - - - - -
B11B 1-B-Corridor 30B Dark Grey Wall Penetration Mortar NAD NA - - - - - - - -
©2011, Mabbett & Associates, Inc. Page 3 of 56 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 3 - Summary of ACM Building Results Syracuse VA Medical Center, Building 1
Percent and Type of Asbestos Sample
Number
Sample Location (Building, Floor, Location)
Description of Material PLM TEM
Estimated Quantity Units Condition
VISN 2 Risk Hazard
Category 1-4*
B11C 1-B-Corridor 30B Dark Grey Wall Penetration Mortar NA NA - - - - - - - -
B11D 1-B-CL16 Dark Grey Wall Penetration Mortar NAD NA - - - - - - - -
B11E 1-B-Basement
Mechanical Room
Dark Grey Wall Penetration Mortar NA NA - - - - - - - -
B11F
1-B-CL55
Basement Mech.
Room
Dark Grey Wall Penetration Mortar NAD NA - - - - - - - -
B12A 1-B-Corridor @CL25 Doorframe Mortar NAD NA - - - - - - - -
B13A 1-B-CL23 Skim Coat on Concrete Wall NAD NA - - - - - - - -
B13B 1-B-CL23 Skim Coat on Concrete Wall NAD NA - - - - - - - -
B13C 1-B-CL23 Skim Coat on Concrete Wall NAD NA - - - - - - - -
B13D 1-B-Basement @ Elevator Lobby
Skim Coat on Concrete Wall NAD NA - - - - - - - -
B14A 1-B-CL23
12” Floor Tile-
Cream with Grey Flecks
NAD NAD - - - - - - - -
B14B 1-B-CL23
12” Floor Tile-
Cream with Grey Flecks
NAD NAD - - - - - - - -
B15A 1-B-CL23 Brown Mastic Under 14A NAD NAD - - - - - - - -
B15B 1-B-CL23 Brown Mastic Under 14A NAD NAD - - - - - - - -
B16A 1-B-CL24-Door Window Glazing Compound NAD NAD - - - - - - - -
B16B 1-B-CL27-Door Window Glazing Compound NAD NAD - - - - - - - -
B17A 1-B-CL15
Premolded Plaster (Mag) Pipe Insulation &
Associated Debris
Chrysotile 3.8%
Amosite 15.4%
NA 30 LF Damaged 2
B17B 1-B-CL15
Premolded Plaster (Mag) Pipe Insulation &
Associated Debris
NA/PS NA Above Above Damaged 2
B18A 1-B-CL14 Spray on Fireproofing-Grey NAD NA - - - - - - - -
B18B 1-B-CL14 Spray on Fireproofing-Grey NAD NA - - - - - - - -
B18C 1-B-CL16 Spray on Fireproofing-Grey NAD NA - - - - - - - -
©2011, Mabbett & Associates, Inc. Page 4 of 56 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 3 - Summary of ACM Building Results Syracuse VA Medical Center, Building 1
Percent and Type of Asbestos Sample
Number
Sample Location (Building, Floor, Location)
Description of Material PLM TEM
Estimated Quantity Units Condition
VISN 2 Risk Hazard
Category 1-4*
B18D 1-B-CL16 Spray on Fireproofing-Grey NAD NA - - - - - - - -
B18E 1-B-CL16 Spray on Fireproofing-Grey NA NA - - - - - - - -
B18F 1-B-AL17 Spray on Fireproofing-Grey NAD NA - - - - - - - -
B18G 1-B-AL17 Spray on Fireproofing-Grey NAD NA - - - - - - - -
B18H 1-B-B05 Spray on Fireproofing-Grey NAD NA - - - - - - - -
B18I 1-B-B05 Spray on Fireproofing-Grey NAD NA - - - - - - - -
B18J 1-B-B05 Spray on Fireproofing-Grey NAD NA - - - - - - - -
B18K 1-B-NL31A-
Chiller Plant
Spray on Fireproofing-Grey NAD NA - - - - - - - -
B18L 1-B-NL31A-
Chiller Plant
Spray on Fireproofing-Grey NAD NA - - - - - - - -
B18M 1-B-NL31A-
Chiller Plant
Spray on Fireproofing-Grey NAD NA - - - - - - - -
B18N 1-Sub-Basement Under BL06
Spray on Fireproofing-Grey NAD NA - - - - - - - -
B18O 1-Sub-Basement Under BL06
Spray on Fireproofing-Grey NAD NA - - - - - - - -
B18P 1-Sub-Basement Under BL06
Spray on Fireproofing-Grey NAD NA - - - - - - - -
B19A 1-B-CL16
Spray on
Fireproofing- Yellow
NAD NA - - - - - - - -
B19B 1-B-CL16
Spray on
Fireproofing- Yellow
NAD NA - - - - - - - -
B19C 1-B-CL16
Spray on
Fireproofing- Yellow
NAD NA - - - - - - - -
B19D 1-B-CL20
Spray on
Fireproofing- Yellow
NAD NA - - - - - - - -
B19E 1-B-CL20
Spray on
Fireproofing- Yellow
NAD NA - - - - - - - -
B19F 1-B-CL20
Spray on
Fireproofing- Yellow
NAD NA - - - - - - - -
B20A 1-B-CL22 Mudded Pipe Fitting NAD NA - - - - - - - -
B20B 1-B-CL22 Mudded Pipe Fitting NAD NA - - - - - - - -
B20C 1-B-CL22 Mudded Pipe Fitting NAD NA - - - - - - - -
B21A 1-B-AL09 Yellow Poured Flooring NAD NAD - - - - - - - -
©2011, Mabbett & Associates, Inc. Page 5 of 56 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 3 - Summary of ACM Building Results Syracuse VA Medical Center, Building 1
Percent and Type of Asbestos Sample
Number
Sample Location (Building, Floor, Location)
Description of Material PLM TEM
Estimated Quantity Units Condition
VISN 2 Risk Hazard
Category 1-4*
B22A 1-B-AL16 Plumbers Putty on Porcelain Sink NAD NAD - - - - - - - -
B22B 1-B-AL16 Plumbers Putty on Porcelain Sink NAD NAD - - - - - - - -
B23A 1-B-AL18B 4” Black Cove Base NAD NAD - - - - - - - -
B24A 1-B-AL18B
Tan Mastic Behind
4” Black Cove Base
NAD NAD - - - - - - - -
B25A 1-B-BL05 Doorframe Caulk NAD NAD - - - - - - - -
B26A 1-B-CL10A Stucco Finish on Plaster Ceiling NAD NA - - - - - - - -
B26B 1-B-CL10A Stucco Finish on Plaster Ceiling NAD NA - - - - - - - -
B26C 1-B-CL10A Stucco Finish on Plaster Ceiling NAD NA - - - - - - - -
B26D 1-B-CL10 Stucco Finish on Plaster Ceiling NAD NA - - - - - - - -
B27A 1-B-CL10A Base Coat Ceiling- Under Stucco NAD NA - - - - - - - -
B27B 1-B-CL10A Base Coat Ceiling- Under Stucco NAD NA - - - - - - - -
B27C 1-B-CL10A Base Coat Ceiling- Under Stucco NAD NA - - - - - - - -
B28A 1-B-Corridor 30A Top Coat on Concrete Floor NAD NA - - - - - - - -
B28B 1-B-Corridor 30A Top Coat on Concrete Floor NAD NA - - - - - - - -
B29A 1-B-AL03 Black Wall Penetration Sealer NAD NAD - - - - - - - -
B29B 1-B-AL03 Black Wall Penetration Sealer NAD NAD - - - - - - - -
B30A 1-B-Corridor 20B Blue Flooring NAD NAD - - - - - - - -
B30B 1-B-Corridor 20B Blue Flooring NAD NAD - - - - - - - -
B31A 1-B-CM01
Black Tar on
Concrete Wall (Type 2)
NAD NAD - - - - - - - -
B31B 1-B-1-B-CM01
Black Tar on
Concrete Wall (Type 2)
NAD NAD - - - - - - - -
B32A 1-B-BL14 Greenish-Yellow Poured Flooring NAD NA - - - - - - - -
B32B 1-B-BL14 Greenish-Yellow Poured Flooring NAD NA - - - - - - - -
B33A 1-B-CL26 Marble Shower Stall Grout NAD NA - - - - - - - -
©2011, Mabbett & Associates, Inc. Page 6 of 56 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 3 - Summary of ACM Building Results Syracuse VA Medical Center, Building 1
Percent and Type of Asbestos Sample
Number
Sample Location (Building, Floor, Location)
Description of Material PLM TEM
Estimated Quantity Units Condition
VISN 2 Risk Hazard
Category 1-4*
B33B 1-B-CL26 Marble Shower Stall Grout NAD NA - - - - - - - -
B34A 1-B-Corridor @ Stairwell 4 6” Tan Cove Base NAD NAD - - - - - - - -
B34B 1-B-Corridor @ Stairwell 4 6” Tan Cove Base NAD NAD - - - - - - - -
B35A 1-B-Corridor @ Stairwell 4 Red Firestop Caulk NAD NAD - - - - - - - -
B35B
1-B-NL35
Basement Corridor
Red Firestop Caulk NAD NAD - - - - - - - -
B36A 1-B-Basement
Mechanical Room
White Duct Tape NAD NA - - - - - - - -
B37A 1-B-BL19
Tar Jacket on
Foam Glass Steam Insulation
NAD NAD - - - - - - - -
B37B 1-B-BL19
Tar Jacket on
Foam Glass Steam Insulation
NAD NAD - - - - - - - -
B38A 1-B-Corridor 30C 2’x4’ Ceiling Tile- Pin Dots NAD NA - - - - - - - -
B38B 1-B-Corridor 30C 2’x4’ Ceiling Tile- Pin Dots NAD NA - - - - - - - -
B38C 1-B-Corridor 30C 2’x4’ Ceiling Tile- Pin Dots NAD NA - - - - - - - -
B38D 1-B-Corridor 30C 2’x4’ Ceiling Tile- Pin Dots NA NA - - - - - - - -
B39A 1-Sub-Basement
Under A&B Wings
Tar on Cork Pipe Insulation NAD NAD 490 LF Minor
Damage 3
B39B 1-Sub-Basement
Under A&B Wings
Tar on Cork Pipe Insulation
Chrysotile <1%
Chrysotile 1.5% Above Above Minor
Damage 3
B39C 1-Sub-Basement
Under A&B Wings
Tar on Cork Pipe Insulation
Chrysotile <1% NA/PS Above Above Minor
Damage 3
B39D 1-Sub-Basement Boiler Room
Tar on Cork Pipe Insulation NAD NA/PS Above Above Minor
Damage 3
©2011, Mabbett & Associates, Inc. Page 7 of 56 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 3 - Summary of ACM Building Results Syracuse VA Medical Center, Building 1
Percent and Type of Asbestos Sample
Number
Sample Location (Building, Floor, Location)
Description of Material PLM TEM
Estimated Quantity Units Condition
VISN 2 Risk Hazard
Category 1-4*
B40A 1-Sub-Basement Boiler Room
Coating on Fiberglass
Insulation Pipe Elbow-8” Steam
NAD NA - - - - - - - -
B40B 1-Sub-Basement Boiler Room
Coating on Fiberglass
Insulation Pipe Elbow-8” Steam
NAD NA - - - - - - - -
B40C 1-Sub-Basement Boiler Room
Coating on Fiberglass
Insulation Pipe Elbow-8” Steam
NAD NA - - - - - - - -
B41A 1-Sub-Basement
Under A&B Wings
Dirt Debris NAD NA - - - - - - - -
GROUND (G) FLOOR THROUGH ELEVENTH FLOOR SAMPLES; A, B AND C WINGS
1A 1-11-Center Water Tank Pad Water Proofing NAD Chrysotile
<1% - - - - - - - -
1B 1-11-Center Water Tank Pad Water Proofing NAD Chrysotile
<1% - - - - - - - -
2A 1-11-West Louver Frame Cement NAD NA - - - - - - - -
2B 1-11-West Louver Frame Cement NAD NA - - - - - - - -
3A 1-11-West Louver Frame Concrete Cap NAD NA - - - - - - - -
3B 1-11-West Louver Frame Concrete Cap NAD NA - - - - - - - -
4A 1-10-East Duct Cloth Seam Sealant NAD NA - - - - - - - -
4B 1-10-East Duct Cloth Seam Sealant NAD NA - - - - - - - -
4C 1-10-East Duct Cloth Seam Sealant NAD NA - - - - - - - -
5A 1-10-NE Door Doorframe Caulk Chrysotile 5.8% NA 42 LF Good 4
5B 1-10-SE Door Doorframe Caulk NA/PS NA/PS Above Above Good 4
6A 1-G-Smoking Shelter
Expansion Joint Caulk Between Steel Column &
CMU Wall
NAD NAD - - - - - - - -
6B 1-G-Smoking Shelter
Expansion Joint Caulk Between Steel Column &
CMU Wall
NAD NAD - - - - - - - -
7A 1-G-Smoking Shelter
Concrete Floor Expansion Joint
Caulk
NAD NAD - - - - - - - -
7B 1-G-Smoking Shelter
Concrete Floor Expansion Joint
Caulk
NAD NAD - - - - - - - -
©2011, Mabbett & Associates, Inc. Page 8 of 56 Vol_II_Survey_Rpt_Syr_Bldg_1 Final 3-30-11
Table 3 - Summary of ACM Building Results Syracuse VA Medical Center, Building 1
Percent and Type of Asbestos Sample
Number
Sample…
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .